Chief Business Officer · Decoy Therapeutics Inc. · Common Stock
Side
A
Value
—
Shares
3,900
Price
—
Executed
Aug 31, 2026
Disclosed
Sep 2, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 31 executedSep 2, 2026 disclosed
DCOY · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Marschel Peter Klaus filed this Form 4 reporting a grant or award of DCOY on Aug 31, 2026. It became public on Sep 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer
Marschel Peter Klauscik:0002079859
Issuer
Decoy Therapeutics Inc.cik:0001615219
Revision history · 0
No field has changed since this record was first ingested.
